Related Experiment Video
Updated: Jun 14, 2025
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
3.1K
Blood Pressure-Lowering Medications, Sodium Reduction, and Blood Pressure
Jing Song1, Liangkai Chen2,3, Hui Xiong4
1Centre for Public Health and Policy, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.S., S.P.-R., G.A.M., F.J.H.).
Hypertension (Dallas, Tex. : 1979)
|September 5, 2024
Summary
Reducing sodium intake significantly lowers blood pressure in treated hypertensive patients. The effectiveness of sodium reduction varies depending on the class of blood pressure-lowering medications used.
Area of Science:
- Cardiovascular Medicine
- Clinical Pharmacology
- Nutritional Science
Background:
- Hypertension management involves both medication and lifestyle changes like sodium reduction.
- The differential impact of sodium reduction across various antihypertensive drug classes remains incompletely understood.
Purpose of the Study:
- To investigate the dose-response relationship between sodium intake reduction and blood pressure control in individuals with hypertension receiving medication.
- To assess how different classes of blood pressure-lowering drugs influence the blood pressure response to sodium reduction.
Main Methods:
- A systematic literature search was conducted up to July 9, 2024, identifying randomized controlled trials.
- Meta-analyses using instrumental variable and random-effects models evaluated the dose-response effect of sodium reduction (measured by 24-hour urinary sodium excretion) on blood pressure.
- Subgroup analyses explored variations based on antihypertensive drug class, age, baseline sodium/blood pressure, and study duration.
Main Results:
- Thirty-five studies with 2885 participants were included, with a median study duration of 28 days.
- A 100 mmol reduction in 24-hour urinary sodium excretion correlated with significant decreases in systolic blood pressure (6.81 mm Hg), diastolic blood pressure (3.85 mm Hg), and mean arterial pressure (4.83 mm Hg).
- The blood pressure-lowering effect of sodium reduction was more pronounced with beta-blockers, renin-angiotensin-aldosterone system inhibitors, and dual therapy, but not significantly different across other subgroups.
Conclusions:
- A clear dose-response association exists between reduced sodium intake and lower blood pressure in treated hypertensive individuals.
- The magnitude of blood pressure reduction from sodium restriction is modulated by the specific class of antihypertensive medication being used.
Related Concept Videos
01:16Antihypertensive Drugs: Action of Diuretics
634
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
634
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
510
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
510
01:25Antihypertensive Drugs: Direct Renin Inhibitors
511
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
511
01:28Factors affecting Blood pressure
3.0K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.0K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
476
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
476
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
614
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
614